Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options.
Where this comes from
- Record sourced from PubMed, PMID 30390047.
- Also identified by DOI 10.1038/s41584-018-0116-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the section 'Combining B cell-targeted therapies' in the originally published version of this article, the 24-week interim analysis for the CALIBRATE study was incorrectly given as the 2- to 4-week interim analysis. This error has now been corrected in the HTML and PDF versions of the manuscript.